- Innovative Powder Formulation of Metformin Designed to Facilitate Adherence by Increasing Patient Choice in the Treatment of Type 2 Diabetes, Now Available in France and the United Kingdom FELTHAM, ...

British regulatory authority approves Glucophage® Extended Release (XR) for type 2 diabetes patients with moderate renal impairment stage 3a or stable chronic heart failure The approval is based on ...

Epidemiological, clinical and experimental evidence suggests a link between type 2 diabetes and Alzheimer's disease (AD). Insulin modulates metabolism of β-amyloid precursor protein (APP) in neurons, ...

Glucophage metformin 850 mg discomfort can often be avoided by beginning at a low dose 1. In healthy individuals, this slight excess is cleared by other mechanisms including uptake by unimpaired ...

Metformin, a generic diabetes treatment usually sold under the brand name Glucophage, may help people with diabetes to lose weight by lowering their appetites. Insulin makes people overweight by ...

Merck KGaA – known as EMD Serono in the US and Canada – has announced in a European work-sharing procedure (WSP) that an extension to the label for metformin products in the EU has been approved – ...

In a European worksharing procedure (WSP), Glucophage® was approved as the firstoral anti-diabetic medication to be used safely from conception to birth. The approval was granted on the basis of Merck ...

A new study comparing three major diabetes drugs -- Avandia, Glucophage (metformin), and Micronase (glyburide) -- shows that all three drugs have pros and cons to consider. Patients and their doctors ...

The history of biguanides can be traced from the use of Galega officinalis commonly known as galega for treating diabetes in medieval Europe 2. Guanidine, the active component of galega, is the parent ...

Powdered versions of the diabetes medication Glucophage (metformin) are to be pulled in the UK due to unforeseen manufacturing issues, manufacturer Merck Serono Ltd has announced. The company has ...

Merck KGaA’s Glucophage, Concor and Euthyrox are three of its key products and the German drugmaker devotes a lot of resources to them, like a new plant in China to produce them for that market. Now ...

In a European worksharing procedure (WSP), Glucophage® was approved as the first oral anti-diabetic medication to be used safely from conception to birth. In a European worksharing procedure (WSP), ...